184 related articles for article (PubMed ID: 1865123)
1. Efficient gene transfer and expression in primary B lymphocytes.
Overell RW; Weisser KE; Hess BW; Ziegler SF; Pleiman CM; Maliszewski C; Grabstein KH
J Immunol Methods; 1991 Jul; 141(1):53-62. PubMed ID: 1865123
[TBL] [Abstract][Full Text] [Related]
2. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
Couture LA; Mullen CA; Morgan RA
Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
[TBL] [Abstract][Full Text] [Related]
3. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
Robinson D; Elliott JF; Chang LJ
Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
[TBL] [Abstract][Full Text] [Related]
5. Retroviral vectors for high-level transgene expression in T lymphocytes.
Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
[TBL] [Abstract][Full Text] [Related]
6. Engineered long terminal repeats of retroviral vectors enhance transgene expression in hepatocytes in vitro and in vivo.
Yamaguchi K; Itoh K; Ohnishi N; Itoh Y; Baum C; Tsuji T; Nagao T; Higashitsuji H; Okanoue T; Fujita J
Mol Ther; 2003 Nov; 8(5):796-803. PubMed ID: 14599813
[TBL] [Abstract][Full Text] [Related]
7. Efficient gene transfer by hybrid retroviral vectors to murine spermatogenic cells.
Danno S; Itoh K; Baum C; Ostertag W; Ohnishi N; Kido T; Tomiwa K; Matsuda T; Fujita J
Hum Gene Ther; 1999 Jul; 10(11):1819-31. PubMed ID: 10446922
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
[TBL] [Abstract][Full Text] [Related]
9. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific activity of heterologous viral promoters in primary rat hepatocytes and Hep G2 cells.
Fang XJ; Keating A; de Villiers J; Sherman M
Hepatology; 1989 Nov; 10(5):781-7. PubMed ID: 2807156
[TBL] [Abstract][Full Text] [Related]
11. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.
Baum C; Hegewisch-Becker S; Eckert HG; Stocking C; Ostertag W
J Virol; 1995 Dec; 69(12):7541-7. PubMed ID: 7494260
[TBL] [Abstract][Full Text] [Related]
12. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy.
Morgan RA; Couture L; Elroy-Stein O; Ragheb J; Moss B; Anderson WF
Nucleic Acids Res; 1992 Mar; 20(6):1293-9. PubMed ID: 1313966
[TBL] [Abstract][Full Text] [Related]
13. Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential.
Weber EL; Cannon PM
Hum Gene Ther; 2007 Sep; 18(9):849-60. PubMed ID: 17767401
[TBL] [Abstract][Full Text] [Related]
14. Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors.
Freas-Lutz DL; Correll PH; Dougherty SF; Xu L; Pluznik DH; Karlsson S
Exp Hematol; 1994 Aug; 22(9):857-65. PubMed ID: 8062885
[TBL] [Abstract][Full Text] [Related]
15. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells.
Robbins PB; Yu XJ; Skelton DM; Pepper KA; Wasserman RM; Zhu L; Kohn DB
J Virol; 1997 Dec; 71(12):9466-74. PubMed ID: 9371608
[TBL] [Abstract][Full Text] [Related]
16. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes.
Kung SK; An DS; Chen IS
J Virol; 2000 Apr; 74(8):3668-81. PubMed ID: 10729143
[TBL] [Abstract][Full Text] [Related]
17. Downstream insertion of the adenovirus tripartite leader sequence enhances expression in universal eukaryotic vectors.
Sheay W; Nelson S; Martinez I; Chu TH; Bhatia S; Dornburg R
Biotechniques; 1993 Nov; 15(5):856-62. PubMed ID: 8267981
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position.
Hoeben RC; Migchielsen AA; van der Jagt RC; van Ormondt H; van der Eb AJ
J Virol; 1991 Feb; 65(2):904-12. PubMed ID: 1702844
[TBL] [Abstract][Full Text] [Related]
19. High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from hemophilia B patient by retroviral vectors.
Dai YF; Qiu XF; Xue JL; Liu ZD
Sci China B; 1992 Feb; 35(2):183-93. PubMed ID: 1581003
[TBL] [Abstract][Full Text] [Related]
20. Production of minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector system.
Wahlfors JJ; Morgan RA
Hum Gene Ther; 1999 May; 10(7):1197-206. PubMed ID: 10340551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
